U.S. FDA proposes shift to annual COVID vaccine shots | Inquirer News

U.S. FDA proposes shift to annual COVID vaccine shots

/ 07:45 AM January 24, 2023

The U.S. health regulator proposes one dose of the latest updated COVID-19 shot annually for healthy adults

FILE PHOTO: A nurse fills up syringes with the coronavirus disease (COVID-19) vaccines for residents who are over 50 years old and immunocompromised and are eligible to receive their second booster shots in Waterford, Michigan, U.S., April 8, 2022. REUTERS/Emily Elconin

The U.S. health regulator on Monday proposed one dose of the latest updated COVID-19 shot annually for healthy adults, similar to the influenza immunization campaign, as it aims to simplify the country’s COVID-vaccine strategy.

The U.S. Food and Drug Administration also asked its panel of external advisers to consider the usage of two COVID vaccine shots a year for some young children, older adults, and persons with compromised immunity. The regulator proposed the need for routine selection of variants for updating the vaccine, similar to the way strains for flu vaccines are changed annually, in briefing documents ahead of a meeting of its panel on Thursday.

Article continues after this advertisement

The FDA hopes annual immunization schedules may contribute to less complicated vaccine deployment and fewer vaccine administration errors, leading to improved vaccine coverage rates.The agency’s proposal was on expected lines, following its announcement of its intention for the update last month.

FEATURED STORIES

READ: US eyes annual shots as updated COVID vaccines roll out

The Biden administration has also been planning for a campaign of vaccine boosters every fall season.

Article continues after this advertisement

Currently, most people in the United States need to first get two doses of the original COVID vaccine spaced at least three to four weeks apart, depending on the vaccine, followed by a booster dose a few months later.

Article continues after this advertisement

READ: Pfizer CEO sees annual COVID-19 vaccine rather than frequent boosters

Article continues after this advertisement

Pfizer’s primary vaccine doses for children and people involve three shots, with the third a bivalent shot given about two months later.

If the panel votes in favor of the proposal, Pfizer Inc and Moderna Inc’s bivalent vaccines, which target both the Omicron and the original variants, would be used for all COVID vaccine doses, and not just as boosters.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, FDA, flu, vaccine

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.